Literature DB >> 11380947

Genomic diversity of natural killer cell receptor genes in three populations.

M Toneva1, V Lepage, G Lafay, N Dulphy, M Busson, S Lester, A Vu-Trien, A Michaylova, E Naumova, J McCluskey, D Charron.   

Abstract

We report the distribution of genes encoding 11 killer cell immunoglobulin-like receptors (KIR) and 2 CD94:NKG2 receptors, in 32 Caucasians, 67 Australian Aborigines and 59 Vietnamese. The inhibitory and the activating KIR genes were found at different frequency in the three populations. No correlation was found between the polymorphism of the KIR genes and the HLA specificities of the tested samples. The most significant KIR associations were 2DL2 with 2DS2; 2DL2 with 2DS3 and 3DL1 with 2DS4 in all three study groups. In Caucasians and Vietnamese 2DS2 was associated with 2DS3 and 2DS1with 3DS1. KIR 2DL1 was strongly associated with three other KIRs: 2DL3, 3DL1 and 2DS4 in Aborigines. The distribution of the KIR phenotypes was different in the three populations. The AA1 phenotype was frequent in Vietnamese (42.4%) and Caucasians (31.2%), but very rare in Aborigines (1.5%). In contrast, the BB7 phenotype was very common for Aborigines (22.4%) and was absent in the two other groups. Our data demonstrate that different associations and putative KIR haplotypes could be distinguished in different populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380947     DOI: 10.1034/j.1399-0039.2001.057004358.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  42 in total

1.  Natural killer cell immunoglobulin-like receptors (KIR) genotypes in two arab populations: will KIR become a genetic landmark between nations?

Authors:  Roni Rayes; Ali Bazarbachi; Georges Khazen; Amira Sabbagh; Ghazi Zaatari; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2007-03-26       Impact factor: 2.316

2.  KIR haplotype content at the allele level in 77 Northern Irish families.

Authors:  D Middleton; A Meenagh; P A Gourraud
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

3.  Amazonian Amerindians exhibit high variability of KIR profiles.

Authors:  Paloma Daguer Ewerton; Mauro de Meira Leite; Milena Magalhães; Leonardo Sena; Eduardo José Melo dos Santos
Journal:  Immunogenetics       Date:  2007-06-06       Impact factor: 2.846

4.  Diversity of killer cell immunoglobulin-like receptor genes in four ethnic groups in China.

Authors:  Yufeng Yao; Lei Shi; Yufen Tao; Keqin Lin; Shuyuan Liu; Liang Yu; Zhaoqing Yang; Wen Yi; Xiaoqin Huang; Hao Sun; Jiayou Chu; Li Shi
Journal:  Immunogenetics       Date:  2011-05-10       Impact factor: 2.846

5.  Diversity of killer cell immunoglobulin-like receptor genes in Southern Turkey.

Authors:  Ozlem Goruroglu Ozturk; Gurbuz Polat; Ugur Atik
Journal:  Mol Biol Rep       Date:  2011-06-08       Impact factor: 2.316

Review 6.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

Review 7.  Cancer treatment and the KIR-HLA system: an overview.

Authors:  Patrizia Leone; Valli De Re; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  Clin Exp Med       Date:  2017-02-10       Impact factor: 3.984

8.  Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations.

Authors:  Marija Velickovic; Zlatibor Velickovic; Heather Dunckley
Journal:  Immunogenetics       Date:  2006-05-30       Impact factor: 2.846

9.  Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

Authors:  Yi Chuan Lee; Soh Ha Chan; Ee Chee Ren
Journal:  Immunogenetics       Date:  2008-07-31       Impact factor: 2.846

10.  KIR gene content diversity in four Iranian populations.

Authors:  Elham Ashouri; Shirin Farjadian; Elaine F Reed; Abbas Ghaderi; Raja Rajalingam
Journal:  Immunogenetics       Date:  2009-06-12       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.